KMD

KMD Bioscience is a biotechnology company and contract research organization (CRO) specializing in antibody discovery and recombinant protein production services. The company utilizes its proprietary phage display technology platform to provide customized solutions for monoclonal antibody development, including camelid VHH (nanobody) and human antibody libraries. Their service offerings also include protein expression in various systems such as E. coli, yeast, insect, and mammalian cells, as well as molecular biology services and stable cell line development. KMD Bioscience supports global pharmaceutical and diagnostic companies in their early-stage research and development efforts by providing high-quality reagents and technical expertise.